Nationwide Multicentric Analysis Regarding In-Hospital Complications After Catheter Ablation of Cardiac Arrhythmias

Read full text
Authors: Florian Doldi, Christian Meyer, Johannes Brachmann, Fabienne Kreimer, Thorsten Lewalter, R Tilz, Malte Kuniss, Ibrahim Akin, Philipp Sommer, Thomas Riemer, Jochen Senges, Lars Eckardt
Cited by: 0
References: 42

Abstract

OBJECTIVE AND BACKGROUND: With the increasing use of catheter ablation for tachyarrhythmias, continuous evaluation of in-hospital complications is essential. This study aimed at analyzing complications associated with catheter ablation for atrial fibrillation (AF), atrial flutter (AFL), and ventricular tachycardia (VT) using nationwide administrative data. METHODS: We conducted a retrospective multicentric data analysis from large German ablation centers between 2018 and 2023. Patients were identified using ICD and OPS codes for AF, AFL, and VT regarding predefined in-hospital complications: mortality, stroke, pericardial tamponade, pulmonary embolism, and vascular complications requiring intervention. RESULTS: Among 19,258 ablation procedures from 11 centers, AF was most common (n = 12,241), followed by AFL (n = 5582) and VT (n = 1435). Major complications occurred in 2.2% (n = 433) of cases. VT ablations had the highest complication rate (9.8%), followed by AF (1.6%) and AFL (1.7%). Pericardial tamponade occurred in 0.9% patients, most commonly in VT ablations (4.0%). Vascular complications requiring intervention were reported in 1.1%, while stroke (0.3%) and pulmonary embolism (0.05%) were rare. In-hospital mortality was highest in VT patients (2.4%), compared to AF (0.08%) and AFL (0.13%). Higher AFL mortality as compared to AF was associated with older age and more comorbidities. Upon exploratory analysis, no statistical association between hospital volume and complication rates could be seen. CONCLUSIONS: In this multicenter analysis, catheter ablation was associated with a low overall complication rate. VT ablations carried the highest risk, highlighting the impact of structural heart disease and comorbidities.

Fields of Study & Subjects

Cardiac Arrhythmias and Treatments Atrial Fibrillation Management and Outcomes Cardiac pacing and defibrillation studies

Publication details

Journal / source
Journal of Cardiovascular Development and Disease
Volume
13
Issue
3
Pages
134–134
Publication date
11 March 2026
Language
EN